ReviewPharmacoEconomics1996
A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer.
J Hutton et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it